参考文献: [1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 6.2024, November 11, 2024. [2]Turner NC, Im SA, Saura C, et al. Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer. N Engl J Med. 2024 Oct 31;391(17):1584-1596. ...
参考文献: [1] Mette S. Van Ramshorst, Erik van Werkhoven, A phase III trial of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2-blockade for HER2+ breast cancer: The TRAIN-2 study (BOOG 2012-03).2017 ASCO abstract 507. [2] Qamar J. Khan, Colleen Bo...
参考文献 [1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024. 来源:丁香园肿瘤时间 封面图源:Pexels 更多肿瘤前沿资讯 关注“oncology论坛”查看 内容合作: 010-59085326,...
[1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024. 作者:黄玉庭;编辑:Bree 题图:图虫创意 投稿:sunjiamei@dxy.cn
[5]Primary results from TROPiCS-02: A randomized phase 3 study of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) in patients (Pts) with hormone receptor–positive/HER2-negative (HR+/HER2-) advanced breast cancer. | Journal of Clinical Oncology ...
[2] Qamar J. Khan, Colleen Bohnenkamp, Taylor Monson,Randomized trial of fixed dose capecitabine compared to standard dose capecitabine in metastatic breast cancer: The X-7/7 trial.2023 ASCO abstract 1007. 长按识别二维码 或点击阅读...
Diagnosis(Clinical)revised:Non-metastatic (M0) IBCLocalized breast cancer: Invasive, non-inflammatory, non-metastatic (M0) 检查,修改末条:仅对存在转移性乳腺癌的体征和症状以及其他临床高风险的患者考虑附加影像学检查 Workup, Last bullet revised: Consider additional...
基于 ASCENT 研究中 SG 展现的健康相关生活质量(HRQoL)的显著改善结果,2024 年更新的 ESMO 转移性乳腺癌在线指南 v. 1.1 版(ESMO Metastatic Breast Cancer Living Guideline V. 1.1)[3]将 SG 治疗 mTNBC 的 ESMO 临床获益量表(ESMO-MCBS)评分,由既往的 4 分调整为最高等级 5 分,这也是目前 mTNBC 二线...
炎性乳腺癌(Inflammatory breast cancer,IBC)是一种罕见的侵袭性乳腺癌,在美国估计占乳腺癌病例的1%～6%。IBC是一种临床诊断,需要乳房三分之一或更多皮肤的充血水肿(橘皮征)。 IBC通常为HR阴性,HER2阳性比例高于常见的导管乳腺癌。IBC基因表达谱的研究证明,IBC存在所有...
Diagnosis(Clinical)revised:Non-metastatic (M0) IBCLocalized breast cancer: Invasive, non-inflammatory, non-metastatic (M0) 检查,修改末条:仅对存在转移性乳腺癌的体征和症状以及其他临床高风险的患者考虑附加影像学检查 Workup, Last bullet revised: Consider additional imaging studies only in the presence of...